Top Medical News
3 days ago
Men with eating disorders including anorexia nervosa (AN), atypical AN or avoidant/restrictive food intake disorder are highly likely to have low bone mineral density, a study has found.
Jairia Dela Cruz, 4 days ago
Denosumab appears to be a more attractive treatment option for glucocorticoid-induced osteoporosis compared with risedronate, with the former yielding superior improvements in spine and hip bone mineral density through 2 years and having a similar safety profile, according to a study.
11 Mar 2019
Tobacco use in patients with fibromyalgia leads to cognitive dysfunction, in addition to worsening of fibromyalgia symptoms and quality of life and aggravation of sleep problems and anxiety, a study has found.
Jairia Dela Cruz, 08 Mar 2019
The odds of a live birth in women with rheumatoid arthritis (RA) receiving assisted reproductive technology (ART) treatment may not be good, and this unfortunate circumstance is related to an impaired chance of conceiving per embryo transfer, according to a study.
07 Mar 2019
Age at menopause is associated with the risk of fractures, such that women who enter menopause before age 45 years are at increased risk, according to a study.
Jairia Dela Cruz, 07 Mar 2019
Using belimumab in the treatment of systemic lupus erythematosus leads to a slower organ damage progression, as well as a smaller magnitude of progression, compared with standard of care alone, according to a study.
06 Mar 2019
Symptom burden is the same or just slightly different in primary and secondary fibromyalgia (FM), according to a study. Moreover, polysymptomatic distress (PSD) scores are more informative than dichotomization into FM/non-FM in terms of severity and severity within diagnosis.
01 Jul 2018
With the objective of establishing a Malaysian consensus on the use of topical NSAIDs in the management of musculoskeletal pain, this meeting brought together experts from various backgrounds, ie, rheumatology, pharmacy, orthopaedics and general medicine. At the meeting, Dr Mary Suma Cardosa delivered a talk on the pathophysiology and effective management of pain, while the lecture by Dr Yeap Swan Sim focused on the management of musculoskeletal and soft-tissue pain. This article presents excerpts from the expert meeting and features the consensus statements agreed during the meeting.
28 Nov 2017
At the 47th Annual Scientific Meeting/Annual General Meeting of the Malaysian Orthopaedic Association, Dr Algis Jovaisas discussed important clinical considerations when it comes to choosing between nonselective nonsteroidal anti-inflammatory drugs (nsNSAIDs) and selective COX-2 inhibitors (coxibs) for the management of acute pain.
01 Jul 2017
At the recent launch of Nurofen® Express by Reckitt Benckiser Malaysia, Ms Joyce McSwan spoke on the importance of managing tension-type headache (TTH), highlighting the roles of drug and non-drug approaches in improving treatment outcomes.
The ESCEO algorithm for the management of knee osteoarthritis (OA) and the role of symptomatic slow-acting drugs for OA (SYSADOAs)
03 Apr 2017
At the International Osteoporosis Foundation Regionals – 6th Asia-Pacific Osteoporosis Meeting in Singapore, Professor Olivier Bruyère shared about the algorithm for the management of knee OA by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). MIMS Doctor also spoke to Professor Jean-Yves Reginster, president of ESCEO about this algorithm and the role of SYSADOAs in the control of pain and prevention of disease progression.
Audrey Abella, 25 Jul 2018
The human anti-interleukin (IL)-1β monoclonal antibody canakinumab continued to show optimal control of disease activity (ie, one or no new flare, no uptitration) in patients with colchicine-resistant familial Mediterranean fever (crFMF), TNF* receptor-associated periodic syndrome (TRAPS), and hyper IgD** syndrome (HIDS)/mevalonate kinase deficiency (MKD) after 112 weeks, according to results from the fourth phase of the CLUSTER*** trial presented at EULAR 2018.
Elvira Manzano, 29 Jun 2018
Treatment with the immunomodulatory agent canakinumab reduces the risk of gout flares by more than half in patients with atherosclerosis, according to the post hoc analysis of the CANTOS* trial.
Pearl Toh, 28 Jun 2018
More than half of the increase in cardiovascular disease (CVD) risk associated with osteoarthritis can be attributed to the use of nonsteroidal anti-inflammatory drugs (NSAIDs), suggests a study presented at the EULAR 2018 Congress.
Elaine Soliven, 28 Jun 2018
Pregnant women with rheumatoid arthritis (RA) are more likely to have premature delivery or baby of low birth weight compared with women without RA, according to a study presented at EULAR 2018.
Roshini Claire Anthony, 27 Jun 2018
Patients with rheumatoid arthritis have a similar incidence of cancer regardless of whether they are treated with tocilizumab or tumour necrosis factor (TNF) inhibitors, according to a study presented at EULAR 2018.
Pearl Toh, 25 Jun 2018
Patients with ankylosing spondylitis (AS) derived a greater benefit from tumour necrosis factor (TNF) inhibitors in terms of less radiographic progression when they also took non-steroidal anti-inflammatory drugs (NSAIDs), suggests a cohort study presented at the EULAR 2018 Congress.
Stephen Padilla, 25 Jun 2018
Although majority of Takayasu arteritis (TA) pregnancies are uneventful and have favourable foetal and maternal outcomes, pregnant TA patients with active disease are at increased risk of developing maternal complications, particularly cardiovascular events, according to a study presented at the European League Against Rheumatism (EULAR) Congress 2018.